MedPath

Effect of misoprostol and oxytocin in controlling of hemorrhage after cesarea

Phase 2
Conditions
Postpartum hemorrhage.
Postpartum haemorrhage
Registration Number
IRCT2013080514275N1
Lead Sponsor
Vice Chancellor for Research of Semnan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
100
Inclusion Criteria

singleton pregnant women; elective cesarean delivery; Gravid 1, 2 (maximum one section)
Exclusion criteria: Patients with preeclampsia (high blood pressure and protein in the urine); diseases cardiovascular diseases; asthma; uterine rupture; uterine leiomyoma or a women with a history of excessive bleeding after childbirth.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood pressure, Heart rate, Shivering, Fever, Nausea and Uterian tone. Timepoint: Each 30 minutes up to 1 hour. Method of measurement: Clinical Assessment.
Secondary Outcome Measures
NameTimeMethod
Hematocrite. Timepoint: Before and 24 hours after intervention. Method of measurement: Laboratory value.
© Copyright 2025. All Rights Reserved by MedPath